Allergy Diagnostics and Therapeutics Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2032
Overview
Allergy Diagnostics and Therapeutics Market is expected to reach US$ 62.92 Bn. by 2032 at a CAGR of 8.9% during the forecast period 2026-2032.
Allergy Diagnostics and Therapeutics Market Overview:
Allergy diagnostics refers to tests carried out to determine the presence of any allergen in an individual’s body and if the person is likely to suffer from or suffers from a particular. Allergy therapeutics, on the other hand, refers to any suitable treatment available for a specific allergy that can avoid or reduce the effects of the allergy.
To know about the Research Methodology :- Request Free Sample Report
Allergy Diagnostics and Therapeutics Market Dynamics:
Rising cases of allergic conditions is fuelling the market growth.
Almost 300 million cases of asthma and 200 to 250 million cases of food allergies were registered, states a study published by the World Allergy Journal. This surge in allergic cases is due to increasing sedentary lifestyles and unhealthy eating habits. These cases are projected to rise over the forecast period. Asthma affects an estimated 300 million people worldwide, with 379 million in India. In India, the number of people with asthma outnumbers those with HIV or tuberculosis. The phase 3 International Study of Asthma and Allergy in Children (ISAAC)1 found a 7% overall prevalence of current wheeze in Indian children aged 6–7 years and 13–14 years, with a higher prevalence of up to 10% in children aged 6–7 years and 13–14 years. Other factors that cause allergies, such as increased pollution from various sources, rapid urbanization, and increased prevalence of respiratory disorders due to the existence of pollens in the atmosphere, all contribute to the market's growth. Developing health care infrastructures, increasing disposable income, and rising geriatric population are some other factors which aid the market growth. Furthermore, numerous initiatives being pursued by key market players as well as regulatory bodies to boost and increase awareness concerning various allergies are the factors that are expected to have a positive impact on the global market’s growth.
Certain factors such as the high cost of allergy diagnostics instruments in small laboratories and physician clinics, the low understanding of allergic diseases in various underdeveloped economies, high capital investments and stringent regulatory affairs may impact negatively on the market growth.
The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Allergy Diagnostics and Therapeutics Market Segment Analysis:
The global Allergy Diagnostics and Therapeutics Market is segmented on the basis of Allergen Type, Product, Tests and End-Users.
Based on the Allergen Type, the Inhaled allergen segment is expected to dominate the market over forecast period. When inhaled allergens come into contact with the membranes of the nostrils, mouth, or lungs, they have an effect on the body. Pollen is the most common allergen inhaled. Certain ingredients, such as soy, peanuts, and fish, contain allergens that can be consumed. Itchy eyes, sneezing, watery eyes, and other allergy symptoms caused by inhaled allergens are some of the common causes. The segment's growth is being aided by increasing pollution levels in the atmosphere, as well as people's changing lifestyles.
Based on the Tests, the in-vivo test segment is expected to hold largest market share and grow at a CAGR of 9.11% during forecast period. The segment growth is attributed to certain benefits such as ease of use, time efficient and broadly accessible. These factors encourage the segment growth.
The in-vitro segment is expected to witness lucrative growth during the forecast period. The growing demand for less invasive diagnostic techniques, as well as high sensitivity and reliable results, are all expected to contribute to the segment's development.
Allergy Diagnostics and Therapeutics Market Regional Insights:
North America accounted for dominant market share in 2022 and is expected to continue the dominance throughout forecast period.
North America is expected to lead global market during forecast period. Factors encouraging the market growth in region include high prevalence of respiratory allergic disorders, increasing awareness of allergy diagnostics, and the adoption of in vitro blood tests. Europe holds the second largest market share owing of its established pharmaceutical industry and growing demand for therapeutics. Asthma is the leading cause large allergic patient pool in North America. It accounted for 3.8 million asthma patients in 2019. The market is expected to develop significantly in the future due to the high death rates associated with asthma and increased investment in asthma in this region.
Allergy Diagnostics and Therapeutics Market Recent Development:
In August 2025, Sanofi introduced Allegra-D in India, a non-drowsy allergy medication designed to provide effective relief from nasal congestion. The tablet formulation contains a fixed-dose combination (FDC) of Fexofenadine Hydrochloride IP (60 mg), a second-generation, non-sedating antihistamine, and Pseudoephedrine Hydrochloride IP (120 mg), a potent nasal decongestant. Allegra-D has received approval from the Drug Controller General of India (DCGI) for use in adults and adolescents aged 12 years and above.
The report also helps in understanding Global Allergy Diagnostics and Therapeutics Market dynamics, structure by analyzing the market segments and project the Global Allergy Diagnostics and Therapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Allergy Diagnostics and Therapeutics Market make the report investor’s guide.
Allergy Diagnostics and Therapeutics Market Scope: Inquire before buying
| Global Allergy Diagnostics and Therapeutics Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | 34.65 USD Billion |
| Forecast Period 2026-2032 CAGR: | 8.9% | Market Size in 2032: | 62.94 USD Billion |
| Segments Covered: | by Allergen Type | Inhaled Allergens Food Allergens Drug Allergens Others |
|
| by Product | Instruments Consumables Luminometers |
||
| by Tests | In Vivo In Vitro |
||
| by End users | Hospitals Diagnostics Labs Research & Development Centers Others |
||
Allergy Diagnostics and Therapeutics Marke, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Allergy Diagnostics and Therapeutics Market Key Players
1. Thermo Fisher Scientific Inc.
2. Siemens Healthineers AG
3. Danaher Corporation
4. bioMérieux SA
5. Eurofins Scientific
6. Stallergenes Greer Ltd
7. ALK-Abelló A/S
8. Omega Diagnostics Group PLC
9. HYCOR Biomedical
10. Minaris Medical America Inc.
11. Lincoln Diagnostics Inc.
12. R-Biopharm AG
13. HAL Allergy Group
14. Canon Medical Systems Corporation
15. Novartis AG
16. Bayer AG
17. Pfizer Inc.
18. Sanofi
19. GSK plc
20. Allergy Therapeutics plc
21. Quest Diagnostics Incorporated
22. Merck KGaA
23. Abbott Laboratories
24. Hitachi Chemical Diagnostics
25. Romer Labs Division Holding GmbH
26. Neogen Corporation
27. DBV Technologies SA
28. Viracor-IBT Laboratories
29. INDOOR Biotechnologies
30. AstraZeneca plc
Frequently Asked Questions:
1. Which region has the largest share in Global Allergy Diagnostics and Therapeutics Market?
Ans: North America region held the highest share in 2022.
2. What is the growth rate of Global Allergy Diagnostics and Therapeutics Market?
Ans: The Global Allergy Diagnostics and Therapeutics Market is growing at a CAGR of 11.1% during forecasting period 2023-2029.
3. What is scope of the Global Allergy Diagnostics and Therapeutics Market report?
Ans: Global Allergy Diagnostics and Therapeutics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Allergy Diagnostics and Therapeutics Market?
Ans: The important key players in the Global Allergy Diagnostics and Therapeutics Market are – bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, Alcon Laboratories, EUROIMMUN AG, INDOOR Biotechnologies, Generic Assays GmbH, ROXALL Medizin GmbH, Astra Biotech GmbH, Demeditec Diagnostics GmbH
5. What is the study period of this Market?
Ans: The Global Allergy Diagnostics and Therapeutics Market is studied from 2022 to 2029.